| Company Profile |  | 0-9 | | A | | B | | C | | D | | E | | F | | G | | H | | I | | J | | K | | L | | M | | N | | O | | P | | Q | | R | | S | | T | | U | | V | | W | | X | | Y | | Z |
Program Information Company Profile Company Market News Interactive Charting Company Financials Company Calendar of Events DR Program News/Events Company Books Close / Open Notices Company Capital Raisings Company Certification Papers Company Corporate Actions Company Dividends / GDN Interest Payments Company DSF Notices Shareholder Information Estimated Fee Calculator
Company Profile
|
Takeda Pharmaceutical Co. Ltd.
(NYSE: TAK)
|
8:00 PM UTC, 04/21/25 | |||
|---|---|---|---|---|
| Last: $14.93 | Change: +0.22 | %Change: +1.50% | Volume: 1,869,865 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 14.86 | Volume: | 1,869,865 | |
|---|---|---|---|---|
| High: | $ 14.95 | Yield(%) | 3.93 | |
| Low: | $ 14.81 | P/E Ratio (ttm): | 34.02 | |
| Dividend ($): | 0.32 | Market Cap ($): | 46.64B | |
| EPS ($) | 0.43 | Shares Out: | 3.17B |
DR Program Information
| Company name | Takeda Pharmaceutical Co. Ltd. |
| Current Book Status | |
| CUSIP | 874060205 (Active) |
| Ratio (ORD:DRS) | 1 :2 |
| DR Ticker | TAK |
| ORD Ticker | 4502 JP |
| DR ISIN | US8740602052 |
| ORD ISIN | JP3463000004 |
| Sedol | 6870445 |
| DR Type | ADR |
| Country | Japan |
| Active Date | 5/10/2010 |
| Inactive Date | |
| GICS Industry | Pharmaceutical |
| Depositary | BoNY (Sponsored) |
| Unsponsored Depositaries | |
| Custodians | |
| Flags | Upgraded |
| Product Milestones | 5/10/10: Unsponsored to sponsored Level 1 conversion and BNY appointed as Depositary. Upgraded to NYSE effective as of 12/24/2018. |
| Comments |
| % Price Change (last 4 weeks): | -3.16 |
|---|---|
| % Price Change (last 13 weeks): | 13.85 |
| % Price Change (last 26 weeks): | 2.65 |
| % Price Change (last 52 weeks): | 11.78 |
| % Price Change (year to date): | 11.10 |
| Return on Equity (%): | 2.08 |
|---|---|
| Return on Assets (%): | 0.97 |
| Return on Invested Capital (%): | 2.57 |
| Gross Profit Margin (%): | 54.53 |
|---|---|
| Net Profit Margin (%): | 3.38 |
| Operating Profit Margin (%): | 12.43 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $14.54 |
|---|---|
| 200-day Moving Average: | $14.03 |
| Avg. Daily Vol. (last 50 days): | 1,892,794 |
| Avg. Daily Vol. (last 200 days): | 1,943,590 |
| 52-wk high: | $15.37 |
| 52-wk low: | $12.57 |
| Bid: | $15.17 |
| Ask: | $15.29 |
|
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
|
|
Takeda Pharmaceutical Co. Ltd.
4-1-1 Dosho-machi Chuo-Ku Osaka OS 540-8645 Phone: 81.6.6204.2111 Fax: 81.6.6204.2880 http://www.takeda.com |
| Earnings (1year) ($): | 0.43 |
|---|---|
| Annual Dividend ($): | 0.52 |
| Current P/E Ratio (ttm): | 34.02 |
| Book Value ($): | 15.31 |
| Cash Flow ($): | 1.92 |
| Price/Earnings (x): | 34.02 |
|---|---|
| Price/Sales (x): | 1.49 |
| Price/Book (x): | 0.91 |
| Price/Cash Flow (x): | 9.91 |
| Quick Ratio (x): | 0.58 |
|---|---|
| Current Ratio (x): | 1.11 |
| LT Debt/Equity (x): | 69.16 |
| Total Debt/Equity (x): | 75.12 |
